Skip to main
BCLI
BCLI logo

BCLI Market Capitalization Overview

Market Cap: $8.74M as of Jun 13, 2025

$8.74M
Past Month+$463.40K (5.60%)
As of Jun 13, 2025, BCLI has a market capitalization of $8.74M. Over the past 30 days, its market cap has increased by 16.47%, while in the last 12 months, it has decreased by -32.55%.

Market capitalization represents the total value of Brainstorm Cell Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

BCLI Market Cap Formula = Stock Price * Shares Outstanding

The market cap of BCLI helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BCLI Market Cap History

DateMarket CapChange
Jun 2, 2025$8.82M+16.47%
May 1, 2025$7.57M+11.47%
Apr 1, 2025$6.79M-23.72%
Mar 3, 2025$8.90M-14.99%
Feb 3, 2025$10.47M-14.25%
Jan 2, 2025$12.21M+25.15%

BCLI End of Year Market Cap History

DateMarket CapChange
2025$8.74M-32.55%
2024$12.95M+4.65%
2023$12.38M-79.36%
2022$59.93M-58.84%
2021$145.61M-8.48%
2020$159.10M

FAQs About Brainstorm Cell Therapeutics (BCLI) Market Cap

As of Jun 13, 2025, the market capitalization of BCLI is $8.74M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Brainstorm Cell Therapeutics’s market capitalization has increased by 5.60%, changing from $8.27M to $8.74M as of Jun 13, 2025.

In the last 3 months, Brainstorm Cell Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Brainstorm Cell Therapeutics’s market capitalization increased from $12.38M in January to $12.95M in December, reflecting a 4.65% change.

In the past five years, BCLI has had a compound annual growth rate (CAGR) of -39.45% in market capitalization. This means its market cap has shrunk at an average rate of -39.45% per year.

Brainstorm Cell Therapeutics (BCLI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.